glp-1 agonist dementia Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease | Journal of Biomedical Science Neuroprotective effects of GLP-1 receptor

Five very important hormones/enzymes are produced by the kidney, viz, 1,25-dihydroxyvitamin D3, erythropoietin, renin, Klotho, and kallikrein (Haussler et al

Traditional 503A compounding refers to when a licensed pharmacist or physician combines, mixes, or alters the ingredients of a drug to produce a custom medication that meets the needs of an individual patient (Lisi, 2021

M.Der-GhazarianT.CortezA

Alzheimers disease is not simply a memory disease. It is a complex neurodegenerative process that often overlaps with insulin resistance, vascular disease, inflammation, mitochondrial stress, sleep disruption, and loss of metabolic resilience